Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
2014
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis
2006
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2015
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
2006
Unsatisfactory knowledge and use of terminology regarding malnutrition, starvation, cachexia and sarcopenia among dietitians
2016
Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review
2018
Nonalcoholic fatty liver disease
2002
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
2011
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
2008
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
1999
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
2006
Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake
2012
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study
2001
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Diet, exercise, and complementary therapies after primary treatment for cancer
2006
Histopathology of Non-Alcoholic Fatty Liver Disease
2009
Nonalcoholic Fatty Liver Disease
2002 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Tamoxifen-induced transient multifocal hepatic fatty infiltration
2000
Endoplasmic Reticulum Stress and the Unfolded Protein Response
2009
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
2001
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Management of weight loss and anorexia
2008
Steatohepatitis in children
2002
Benefits of lifestyle modification in NAFLD
2007
Intestinal microbiota and nonalcoholic steatohepatitis
2017
Rapid DNA Methylation Changes after Exposure to Traffic Particles
2009
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Apolipoprotein synthesis in nonalcoholic steatohepatitis
2002
Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease
2008
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
2006
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
2008
Non‐alcoholic fatty liver disease: An overview
2002
AGA technical review on nonalcoholic fatty liver disease
2002
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
2002
The metabolic syndrome
2005 Standout
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
Mini-Nutritional Assessment Predicts Functional Status and Quality of Life of Patients With Hepatocellular Carcinoma in Taiwan
2012
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
2001
Non-alcoholic fatty liver disease
2021 Standout
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
2008
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
2001
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance
2006
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
2018
Beyond genetics: epigenetic code in chronic kidney disease
2010
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
2011
Palliative Care
2009
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
2000
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
2008
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
2008
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Sarcopenia
2019 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Role of Supportive Care for Terminal Stage Hepatocellular Carcinoma
2014
Unexplained Elevations in Alanine Aminotransferase in Individuals with the Metabolic Syndrome: Results from the Third National Health and Nutrition Survey (NHANES III)
2005
A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
2009
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
Cellular and Molecular Mechanisms of Liver Injury
2008
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Cancer: disease and nutrition are key determinants of patients? quality of life
2004
Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
2011
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
2002
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
2008
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
2016
Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment
2009
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
2008
Hepatocellular Carcinoma
2011 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Mechanisms of non-alcoholic steatohepatitis
2004
The Antioxidants and Pro-Antioxidants Network: An Overview
2004
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Chronic Kidney Disease
2016 Standout
Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis
2018
Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population
2009
Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
2015
Nutrition and Aberrant DNA Methylation Patterns in Atherosclerosis: More than Just Hyperhomocysteinemia? ,
2005
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Causes and Metabolic Consequences of Fatty Liver
2008
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Nonalcoholic Fatty Liver Disease
2001 Standout
Bioactive compounds in seaweed: functional food applications and legislation
2011 Standout
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey
2010
The ins and outs of mitochondrial dysfunction in NASH
2004
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
2016
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
2014
Effects of omega-3 fatty acids on cancer.
2005
Insulin Resistance, the Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease
2005
Increase in long-chain polyunsaturated fatty acid n−6/n−3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
2004
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
2015
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children
2000
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of M. Camilo being referenced
Nonalcoholic steatohepatitis
1996
Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy
2005
Bile acid levels are increased in the liver of patients with steatohepatitis
2008
Nutritional risk screening in surgery: Valid, feasible, easy!
2011
Tamoxifen-associated steatohepatitis - report of three cases
1995
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
2002
Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients
2004
Nutritional Deterioration in Cancer: The Role of Disease and Diet
2003
Cancer wasting and quality of life react to early individualized nutritional counselling!
2006
How different is the dietary pattern in non-alcoholic steatohepatitis patients?
2006
Validation of the Malnutrition Universal Screening Tool (MUST) in cancer
2011
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
2004
Nonalcoholic Steatohepatitis—A Long-Term Follow-Up Study: Comparison with Alcoholic Hepatitis in Ambulatory and Hospitalized Patients
2003
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
1999
Does nutrition influence quality of life in cancer patients undergoing radiotherapy?
2003
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
2005
A critical approach to nutritional assessment in critically ill patients
2002
689 Nutrition & patient outcomes: prospective randomised controlled trial in head-neck cancer patients undergoing radiotherapy
2003
Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiotherapy
2005
Disease-related Malnutrition: An Evidence-based Approach to Treatment
2003
Taurine: a conditionally essential amino acid in humans? An overview in health and disease.
2003
Increased Homocysteine and S-Adenosylhomocysteine Concentrations and DNA Hypomethylation in Vascular Disease
2003